Biocept reported $10.34M in Cost of Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbott ABT:US $ 4933M 54M
Becton, Dickinson and BDX:US $ 2574M 132M
Biocept BIOC:US $ 10.34M 0.3M
General Electric GE:US $ 13605M 777M
Illumina ILMN:US $ 395M 13M
Quest Diagnostics DGX:US $ 1611M 32M
Thermo Fisher Scientific TMO:US $ 6240M 114M